According to Strides Pharma's latest financial reports the company has a price-to-book ratio of 4.05.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.99 | 121.04% |
2022-12-31 | 1.35 | -17.92% |
2021-12-31 | 1.65 | -43.25% |
2020-12-31 | 2.90 | 141.59% |
2019-12-31 | 1.20 | -28.83% |
2018-12-31 | 1.69 | -35.78% |
2017-12-31 | 2.63 | -26.2% |
2016-12-31 | 3.56 | -43.69% |
2015-12-31 | 6.32 |